TPMT expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.08655315248052E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.29749544441893E-11 |
Normal-vs-Stage2 |
4.34979999996976E-06 |
Normal-vs-Stage3 |
1.64779301314866E-12 |
Normal-vs-Stage4 |
2.07500683302442E-13 |
Stage1-vs-Stage2 |
7.215600E-01 |
Stage1-vs-Stage3 |
2.206100E-02 |
Stage1-vs-Stage4 |
4.643700E-02 |
Stage2-vs-Stage3 |
1.480370E-01 |
Stage2-vs-Stage4 |
1.595410E-01 |
Stage3-vs-Stage4 |
9.751200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.95474797143925E-13 |
Normal-vs-AfricanAmerican |
1.89940285721946E-11 |
Normal-vs-Asian |
1.731920E-02 |
Caucasian-vs-AfricanAmerican |
1.971420E-01 |
Caucasian-vs-Asian |
6.950800E-01 |
AfricanAmerican-vs-Asian |
3.867000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.65867319878998E-12 |
Normal-vs-Female |
4.52069492951068E-11 |
Male-vs-Female |
1.043630E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.3636005092319E-10 |
Normal-vs-Age(41-60Yrs) |
1.71285208239169E-12 |
Normal-vs-Age(61-80Yrs) |
1.2756462552943E-13 |
Normal-vs-Age(81-100Yrs) |
1.84496999999784E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.577900E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.209800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.009800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.231980E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.459400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.448200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.18860000029176E-07 |
Normal-vs-Grade 2 |
1.76747505520325E-13 |
Normal-vs-Grade 3 |
1.14760423386429E-11 |
Normal-vs-Grade 4 |
<1E-12 |
Grade 1-vs-Grade 2 |
9.698200E-01 |
Grade 1-vs-Grade 3 |
8.463200E-01 |
Grade 1-vs-Grade 4 |
2.464400E-02 |
Grade 2-vs-Grade 3 |
7.941000E-01 |
Grade 2-vs-Grade 4 |
1.86759999999397E-05 |
Grade 3-vs-Grade 4 |
4.21879999999986E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
5.87580000210863E-08 |
Normal-vs-ccB subtype |
<1E-12 |
ccA subtype-vs-ccB subtype |
1.62547753035369E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62769797640294E-12 |
Normal-vs-N1 |
9.96690000000244E-05 |
N0-vs-N1 |
6.822400E-01 |
|
|